PSIL Performance — AdvisorShares Psychedelics ETF
Data updated: 2026-09-10
PSIL returned +37.21% year to date and +88.39% over one year to Jun 2026. The annualised 3-year return is +13.51%. The fund beat its Global Health Care Equity category average: $100 invested three years ago grew to $146, against $130 for the category, and to $188 over one year, against $124. Volatility over the past three years was 46.15% a year. In the 12 months to Jun 2026 the fund took in a net $22.3M, and assets reached $44.43M.
PSIL Growth of $100
What $100 invested in AdvisorShares Psychedelics ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Health Care Equity category average over the same months.
| Period | PSIL | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $188 | $124 |
| 3 years (Jul 2023 – Jun 2026) | $146 | $130 |
| Since data start (Sep 2021 – Jun 2026) | $27 | $101 |
PSIL Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +37.21% |
| 1 year | +88.39% |
| 3 years (annualised) | +13.51% |
PSIL Annual Returns
Calendar-year total returns of AdvisorShares Psychedelics ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +37.21% |
| 2025 | +73.45% |
| 2024 | −19.45% |
| 2023 | −24.50% |
| 2022 | −66.01% |
| 2021 (Sep–Dec) | −44.18% |
PSIL Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −3.0% | +1.5% | +0.5% | +16.7% | +8.2% | +9.8% | — | — | — | — | — | — |
| 2025 | +12.6% | +2.3% | −8.0% | −1.7% | +16.1% | +4.5% | +18.4% | +4.0% | +11.5% | +5.5% | −4.2% | −1.1% |
| 2024 | +1.0% | +2.3% | −1.9% | −12.9% | −5.9% | −16.7% | +7.6% | −16.6% | −11.4% | +56.7% | +2.0% | −8.3% |
| 2023 | +14.6% | −3.8% | −14.5% | −3.9% | +1.2% | +8.0% | +5.8% | −15.8% | −5.0% | −8.6% | −10.4% | +10.1% |
| 2022 | −18.1% | −9.2% | −9.0% | −21.8% | −3.7% | −10.2% | +10.5% | +35.2% | −30.1% | −9.6% | −5.3% | −17.0% |
| 2021 | — | — | — | — | — | — | — | — | −9.8% | +4.0% | −21.1% | −24.6% |
PSIL Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 46.15%
- 3-year Sharpe ratio: 0.20 (vs 4.5% risk-free rate)
- Best month: +56.67% (Oct 2024)
- Worst month: −16.74% (Jun 2024)
PSIL Fund Flows
Monthly money in and out of AdvisorShares Psychedelics ETF, from SEC Form N-PORT.
- 12-month net flow: $22.3M
- 12-month gross sales (incl. reinvestments): $22.3M
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.1M | $0 | $4.1M |
| May 2026 | $1.2M | $0 | $1.2M |
| Apr 2026 | $9.2M | $0 | $9.2M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $2.0M | $0 | $2.0M |
| Dec 2025 | $1.1M | $0 | $1.1M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $2.0M | $0 | $2.0M |
| Sep 2025 | $1.8M | $0 | $1.8M |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $923K | $0 | $923K |
PSIL Assets Under Management
Net assets of AdvisorShares Psychedelics ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $44.43M |
| 2026-03-31 | $20.25M |
| 2025-12-31 | $18.48M |
| 2025-09-30 | $17.12M |
| 2025-06-30 | $10.35M |
| 2025-03-31 | $8.68M |
| 2024-12-31 | $6.31M |
| 2024-09-30 | $4.41M |
| 2024-06-28 | $5.62M |
| 2024-03-28 | $7.26M |
| 2023-12-29 | $6.43M |
| 2023-09-29 | $6.51M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.